Margaret Ackerman - Publications

Affiliations: 
School of Education Liberty University, Lynchburg, VA, United States 
Area:
Community College Education, Mathematics Education

33 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Xu S, Carpenter MC, Spreng RL, Neidich SD, Sarkar S, Tenney D, Goodman D, Sawant S, Jha S, Dunn B, Juliana McElrath M, Bekker V, Mudrak SV, Flinko R, Lewis GK, ... ... Ackerman ME, et al. Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans. Npj Vaccines. 7: 90. PMID 35927399 DOI: 10.1038/s41541-022-00514-9  0.333
2022 Brady JM, Phelps M, MacDonald SW, Lam EC, Nitido A, Parsons D, Boutros CL, Deal CE, Garcia-Beltran WF, Tanno S, Natarajan H, Ackerman ME, Vrbanac VD, Balazs AB. Antibody-mediated prevention of vaginal HIV transmission is dictated by IgG subclass in humanized mice. Science Translational Medicine. 14: eabn9662. PMID 35895834 DOI: 10.1126/scitranslmed.abn9662  0.32
2021 Tolbert WD, Nguyen DN, Tuyishime M, Crowley AR, Chen Y, Jha S, Goodman D, Bekker V, Mudrak SV, DeVico AL, Lewis GK, Theis JF, Pinter A, Moody MA, Easterhoff D, ... ... Ackerman M, et al. Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s. Frontiers in Immunology. 12: 787603. PMID 35069563 DOI: 10.3389/fimmu.2021.787603  0.304
2021 Sherburn R, Tolbert WD, Gottumukkala S, Hederman AP, Beaudoin-Bussières G, Stanfield-Oakley S, Tuyishime M, Ferrari G, Finzi A, Ackerman ME, Pazgier M. Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions. Vaccines. 9. PMID 34579212 DOI: 10.3390/vaccines9090975  0.341
2021 Pollara J, Tay MZ, Edwards RW, Goodman D, Crowley AR, Edwards RJ, Easterhoff D, Conley HE, Hoxie T, Gurley T, Jones C, Machiele E, Tuyishime M, Donahue E, Jha S, ... ... Ackerman ME, et al. Functional Homology for Antibody-Dependent Phagocytosis Across Humans and Rhesus Macaques. Frontiers in Immunology. 12: 678511. PMID 34093580 DOI: 10.3389/fimmu.2021.678511  0.319
2021 Lu P, Guerin DJ, Lin S, Chaudhury S, Ackerman ME, Bolton DL, Wallqvist A. Immunoprofiling Correlates of Protection Against SHIV Infection in Adjuvanted HIV-1 Pox-Protein Vaccinated Rhesus Macaques. Frontiers in Immunology. 12: 625030. PMID 34046030 DOI: 10.3389/fimmu.2021.625030  0.314
2021 Spencer DA, Malherbe DC, Vázquez Bernat N, Ádori M, Goldberg B, Dambrauskas N, Henderson H, Pandey S, Cheever T, Barnette P, Sutton WF, Ackerman ME, Kobie JJ, Sather DN, Karlsson Hedestam GB, et al. Polyfunctional Tier 2-Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor. Journal of Immunology (Baltimore, Md. : 1950). PMID 33472907 DOI: 10.4049/jimmunol.2001082  0.317
2020 Butler SE, Crowley AR, Natarajan H, Xu S, Weiner JA, Bobak CA, Mattox DE, Lee J, Wieland-Alter W, Connor RI, Wright PF, Ackerman ME. Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals. Frontiers in Immunology. 11: 618685. PMID 33584712 DOI: 10.3389/fimmu.2020.618685  0.3
2020 Mdluli T, Jian N, Slike B, Paquin-Proulx D, Donofrio G, Alrubayyi A, Gift S, Grande R, Bryson M, Lee A, Dussupt V, Mendez-Riveria L, Sanders-Buell E, Chenine AL, Tran U, ... ... Ackerman ME, et al. RV144 HIV-1 vaccination impacts post-infection antibody responses. Plos Pathogens. 16: e1009101. PMID 33290394 DOI: 10.1371/journal.ppat.1009101  0.326
2020 Fischinger S, Dolatshahi S, Jennewein MF, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Michael NL, Vasan S, Ackerman ME, Streeck H, Alter G. IgG3 collaborates with IgG1 and IgA to recruit effector function in RV144 vaccinees. Jci Insight. PMID 33031099 DOI: 10.1172/jci.insight.140925  0.318
2020 Om K, Paquin-Proulx D, Montero M, Peachman K, Shen X, Wieczorek L, Beck Z, Weiner JA, Kim D, Li Y, Mdluli T, Shubin Z, Bryant C, Sharma V, Tokarev A, ... ... Ackerman ME, et al. Adjuvanted HIV-1 vaccine promotes antibody-dependent phagocytic responses and protects against heterologous SHIV challenge. Plos Pathogens. 16: e1008764. PMID 32881968 DOI: 10.1371/Journal.Ppat.1008764  0.32
2020 Fischinger S, Shin S, Boudreau CM, Ackerman M, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kim JH, Robb ML, Michael NL, O'Connell RJ, Vasan S, Streeck H, Alter G. Protein-based, but not viral vector alone, HIV vaccine boosting drives an IgG1-biased polyfunctional humoral immune response. Jci Insight. 5. PMID 32554928 DOI: 10.1172/Jci.Insight.135057  0.343
2020 Lai JI, Eszterhas SK, Brooks SA, Guo C, Zolla-Pazner S, Seaman MS, Bailey-Kellogg C, Griswold KE, Ackerman ME. Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity. Vaccine. PMID 32192810 DOI: 10.1016/J.Vaccine.2020.03.010  0.309
2019 Richardson SI, Lambson BE, Crowley AR, Bashirova A, Scheepers C, Garrett N, Abdool Karim S, Mkhize NN, Carrington M, Ackerman ME, Moore PL, Morris L. IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody. Plos Pathogens. 15: e1008064. PMID 31841557 DOI: 10.1371/journal.ppat.1008064  0.306
2019 Pittala S, Morrison KS, Ackerman ME. Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1. Current Opinion in Hiv and Aids. PMID 31033729 DOI: 10.1097/COH.0000000000000558  0.303
2018 Ackerman ME, Das J, Pittala S, Broge T, Linde C, Suscovich TJ, Brown EP, Bradley T, Natarajan H, Lin S, Sassic JK, O'Keefe S, Mehta N, Goodman D, Sips M, et al. Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV. Nature Medicine. PMID 30177821 DOI: 10.1038/S41591-018-0161-0  0.323
2018 Lofano G, Gorman MJ, Yousif AS, Yu WH, Fox JM, Dugast AS, Ackerman ME, Suscovich TJ, Weiner J, Barouch D, Streeck H, Little S, Smith D, Richman D, Lauffenburger D, et al. Antigen-specific antibody Fc glycosylation enhances humoral immunity via the recruitment of complement. Science Immunology. 3. PMID 30120121 DOI: 10.1126/Sciimmunol.Aat7796  0.302
2018 Miller-Novak LK, Das J, Musich TA, Demberg T, Weiner JA, Venzon DJ, Mohanram V, Vargas-Inchaustegui DA, Tuero I, Ackerman ME, Alter G, Robert-Guroff M. Analysis of complement-mediated lysis of SIV and SIV-infected cells reveals sex differences in vaccine-induced immune responses in Rhesus macaques. Journal of Virology. PMID 30021899 DOI: 10.1128/Jvi.00721-18  0.322
2018 Richardson SI, Chung AW, Natarajan H, Mabvakure B, Mkhize NN, Garrett N, Abdool Karim S, Moore PL, Ackerman ME, Alter G, Morris L. HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies. Plos Pathogens. 14: e1006987. PMID 29630668 DOI: 10.1371/Journal.Ppat.1006987  0.303
2018 Alter G, Dowell KG, Brown EP, Suscovich TJ, Mikhailova A, Mahan AE, Walker BD, Nimmerjahn F, Bailey-Kellogg C, Ackerman ME. High-resolution definition of humoral immune response correlates of effective immunity against HIV. Molecular Systems Biology. 14: e7881. PMID 29581149 DOI: 10.15252/Msb.20177881  0.322
2017 Bradley T, Pollara J, Santra S, Vandergrift N, Pittala S, Bailey-Kellogg C, Shen X, Parks R, Goodman D, Eaton A, Balachandran H, Mach LV, Saunders KO, Weiner JA, Scearce R, ... ... Ackerman ME, et al. Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge. Nature Communications. 8: 15711. PMID 28593989 DOI: 10.1038/Ncomms15711  0.327
2017 Brown EP, Dowell KG, Boesch AW, Normandin E, Mahan AE, Chu T, Barouch DH, Bailey-Kellogg C, Alter G, Ackerman ME. Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles. Journal of Immunological Methods. PMID 28163018 DOI: 10.1016/J.Jim.2017.01.010  0.325
2017 Ackerman ME, Barouch DH, Alter G. Systems serology for evaluation of HIV vaccine trials. Immunological Reviews. 275: 262-270. PMID 28133810 DOI: 10.1111/Imr.12503  0.327
2016 Sips M, Krykbaeva M, Diefenbach TJ, Ghebremichael M, Bowman BA, Dugast AS, Boesch AW, Streeck H, Kwon DS, Ackerman ME, Suscovich TJ, Brouckaert P, Schacker TW, Alter G. Fc receptor-mediated phagocytosis in tissues as a potent mechanism for preventive and therapeutic HIV vaccine strategies. Mucosal Immunology. PMID 26883728 DOI: 10.1038/Mi.2016.12  0.312
2015 Chung AW, Kumar MP, Arnold KB, Yu WH, Schoen MK, Dunphy LJ, Suscovich TJ, Frahm N, Linde C, Mahan AE, Hoffner M, Streeck H, Ackerman ME, McElrath MJ, Schuitemaker H, et al. Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology. Cell. 163: 988-98. PMID 26544943 DOI: 10.1016/J.Cell.2015.10.027  0.428
2015 Storcksdieck Genannt Bonsmann M, Niezold T, Temchura V, Pissani F, Ehrhardt K, Brown EP, Osei-Owusu NY, Hannaman D, Hengel H, Ackerman ME, Streeck H, Nabi G, Tenbusch M, Überla K. Enhancing the Quality of Antibodies to HIV-1 Envelope by GagPol-Specific Th Cells. Journal of Immunology (Baltimore, Md. : 1950). 195: 4861-72. PMID 26466954 DOI: 10.4049/jimmunol.1501377  0.302
2015 Choi I, Chung AW, Suscovich TJ, Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, O'Connell RJ, Francis D, Robb ML, Michael NL, Kim JH, Alter G, Ackerman ME, Bailey-Kellogg C. Machine learning methods enable predictive modeling of antibody feature:function relationships in RV144 vaccinees. Plos Computational Biology. 11: e1004185. PMID 25874406 DOI: 10.1371/Journal.Pcbi.1004185  0.332
2014 Chung AW, Ghebremichael M, Robinson H, Brown E, Choi I, Lane S, Dugast AS, Schoen MK, Rolland M, Suscovich TJ, Mahan AE, Liao L, Streeck H, Andrews C, Rerks-Ngarm S, ... ... Ackerman ME, et al. Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Science Translational Medicine. 6: 228ra38. PMID 24648341 DOI: 10.1126/Scitranslmed.3007736  0.326
2014 Lai JI, Licht AF, Dugast AS, Suscovich T, Choi I, Bailey-Kellogg C, Alter G, Ackerman ME. Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers. Journal of Virology. 88: 2799-809. PMID 24352471 DOI: 10.1128/Jvi.03130-13  0.319
2013 Ackerman ME, Alter G. Opportunities to exploit non-neutralizing HIV-specific antibody activity. Current Hiv Research. 11: 365-77. PMID 24191934 DOI: 10.2174/1570162X113116660058  0.307
2013 Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, Dugast AS, Heizen EL, Ercan A, Choi I, Streeck H, Nigrovic PA, Bailey-Kellogg C, Scanlan C, Alter G. Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. The Journal of Clinical Investigation. 123: 2183-92. PMID 23563315 DOI: 10.1172/Jci65708  0.32
2013 Ackerman ME, Dugast AS, McAndrew EG, Tsoukas S, Licht AF, Irvine DJ, Alter G. Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcγR2a and FcγR2b. Journal of Virology. 87: 5468-76. PMID 23468489 DOI: 10.1128/Jvi.03403-12  0.319
2012 Ackerman ME, Dugast AS, Alter G. Emerging concepts on the role of innate immunity in the prevention and control of HIV infection. Annual Review of Medicine. 63: 113-30. PMID 22077718 DOI: 10.1146/Annurev-Med-050310-085221  0.303
Show low-probability matches.